CAMP4 THERAPEUTICS CORPORATION Share Price & Technical Analysis
CAMP · $4.40 (-2.22%)
Healthcare / Biotechnology
$4.40
-2.22%
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was fo…
Price chart
Seasonality
May has 2 positive and 0 negative years (last 3 years shown)
10% return in May, 5% avg return in past 3 year May month.
-14% return in 2026, 18% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -40% | 25% | -4% | -5% | 10% | – | – | – | – | – | – | – | -14% |
| 25 | -8% | 7% | -17% | -56% | 5% | -25% | 7% | -6% | 88% | 40% | -10% | 65% | 90% |
| 24 | – | – | – | – | – | – | – | – | – | -5% | -54% | 6% | -54% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Neutral
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$233.15M
P/E ratio
—
52W high
$7.75
52W low
$1.30
Volume
60,657
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is CAMP4 THERAPEUTICS CORPORATION share price today?
- CAMP4 THERAPEUTICS CORPORATION (CAMP) last traded around $4.40 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CAMP have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CAMP. Download the app for real-time alerts.
- How can I analyze CAMP4 THERAPEUTICS CORPORATION stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.